Insider Trading January 22, 2026

Progressive's Chief Strategy Officer Executes $337K Stock Sale Amid Mixed Analyst Views

Andrew J. Quigg divests shares via pre-arranged plan as Progressive launches new pet insurance product and faces varied analyst ratings

By Marcus Reed PGR
Progressive's Chief Strategy Officer Executes $337K Stock Sale Amid Mixed Analyst Views
PGR

Andrew J. Quigg, Chief Strategy Officer of Progressive Corp, sold 1,649 shares worth approximately $337,000 under a structured trading plan. The insurer recently introduced a pet insurance offering across numerous U.S. states. Analyst opinions on Progressive vary, with some upgrades balanced by lowered price targets reflecting regional rate challenges and policy growth concerns.

Key Points

  • Progressive's Chief Strategy Officer Andrew J. Quigg sold 1,649 shares valued at approximately $337,000 under a pre-established 10b5-1 plan.
  • Progressive launched a new pet insurance product available in 43 states and D.C., underwritten by the company and administered by Companion Protect.
  • Analyst sentiment is mixed: Barclays upgraded to Overweight expecting growth in personal insurance, while BMO Capital and Wells Fargo lowered price targets due to regional rate cuts and policy growth challenges.

On January 21, 2026, Andrew J. Quigg, the Chief Strategy Officer at Progressive Corp (NYSE:PGR), divested 1,649 shares of the insurer's common stock in a transaction disclosed via a Securities and Exchange Commission Form 4 filing. The shares were sold at a unit price of $204.35, resulting in proceeds totaling $336,973.

Following this sale, Quigg retains a direct ownership stake of 39,626.185 shares in Progressive. Notably, this sale was conducted under a pre-approved 10b5-1 trading plan established on January 30, 2025, which allows insiders to transact shares under set parameters, mitigating concerns about timing or insider knowledge.

In parallel developments, Progressive Insurance has expanded its product suite by introducing a pet insurance plan targeting pet owners who want to better manage unanticipated veterinary expenses. This newly launched offering is available in 43 states plus the District of Columbia. The product is both underwritten by Progressive and administered by Companion Protect, marking the company’s intent to diversify its insurance portfolio beyond traditional lines.

Market analysts hold differing perspectives on Progressive's stock outlook. Barclays recently upgraded Progressive’s rating to Overweight, highlighting an optimistic growth trajectory forecasted in personal lines insurance underwriting through 2026.

Conversely, BMO Capital has revised its price target downward to $239.00 from an earlier $253.00, pointing to reduced rates in Florida as one factor tempering expectations. Wells Fargo has similarly lowered its price target to $242.00, citing a challenging environment for growth. Further, BMO Capital made an additional revision, setting a price target at $253.00 in light of Progressive's November shortfall in policies in force, particularly within the Agency channel.

Risks

  • Potential adverse impact on Progressive’s growth prospects from rate reductions in Florida, affecting personal insurance underwriting.
  • Lower-than-expected policy-in-force numbers in November, especially in the Agency channel, may signal challenges in maintaining or growing market share.
  • Challenging growth environment noted by Wells Fargo could hamper Progressive's ability to expand and improve financial performance.

More from Insider Trading

Symbotic Accounting Chief Disposes $457,722 in Shares as Company Prices 10M-Share Offering; Goldman Lowers Rating Feb 2, 2026 Wintrust Financial EVP Sells 5,000 Shares as Firm Announces Dividend Hike and Multiple Price-Target Upgrades Jan 30, 2026 Cantor Fitzgerald Affiliates Dispose of Satellogic Shares in $2.94M Transaction Block Jan 30, 2026 Navan Interim CFO Executes $37,044 Sell-to-Cover Transaction Jan 30, 2026 Bluescape entity disposes of $4.2M in Riley Exploration stock amid company asset sale and capital actions Jan 30, 2026